Indivior PLC Ordinary Shares Q3 2025 Earnings Recap

INDV Q3 2025 October 31, 2025

Get alerts when INDV reports next quarter

Indivior PLC reported strong Q3 2025 results with a 15% increase in SUBLOCADE sales, driving a 2% rise in total net revenue, and raised full year guidance on adjusted EBITDA growth.

Earnings Per Share Beat

$0.72 vs $0.38 est.

+89.5% surprise

Revenue Beat

314000000 vs 306220000 est.

+2.5% surprise

See INDV alongside your other holdings

Add to your portfolio — free

Key Takeaways

Adjusted EBITDA grew 14% year-over-year, reflecting improved operational efficiency.
Raised full year 2025 revenue guidance, projecting a 10% increase in SUBLOCADE net revenue.
Implemented $150 million in annual cost reductions through organizational simplification and strategic focus.
Continued stability observed in SUBOXONE Film pricing in the U.S.
Solid unit dispense growth of 8% for SUBLOCADE, underscoring effective commercial execution strategies.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit INDV on AllInvestView.